Tert-butyln-[3-(trifluoromethyl)-1-bicyclo[1.1.1]pentanyl]carbamate, 98%, 100mg

Ponceau solution 0.1% in 5% acetic acid, 1L

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Benzyl-propyl-amine, 95.0%, 10g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1,8-naphthyridin-2(1H)-one, 98%, 1g

n-(3-Methoxyphenyl)prop-2-enamide, 97%, 250mg

2-Chlorobenzoic acid, 95.0%, 100g

1-TERT-BUTYL 5-METHYL INDOLINE-1,5-DICARBOXYLATE, 95.0%, 250mg

1,4-Difluoroanthraquinone, 95.0%, 10g

1-[4-(cyclopentylamino)-2-(methylsulfanyl)pyrimidin-5-yl]ethan-1-one, 98%, 250mg

2-Amino-5-chloro-3-methylbenzoic acid, 95.0%, 10g

4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)morpholine, 98+%, 100mg

Cyclopentan, min. 95 %, zur Synthese, 2.5 l, Glasverpackung